P149 The Relationship Between Insulin Resistance Scores Parameters and Chemerin in Diabetic and Obese Patients

Abstract Background Chemerin represents a recently discovered chemokine influencing adipocyte function, lipolysis, apparently positively associated with insulin resistance. Purpose To evaluate the relationship between chemerin-insulin resistance scores in obese/diabetic patients. Methods 88 patients...

Full description

Bibliographic Details
Main Authors: Angela Cozma, Adriana Fodor, Vasile Negrean, Dorel Sampelean, Ionut Minciuna, Monica Oltean, Ionela Popovici, Sorina Coste, Alexandra Dadarlat, Dana Pop, Olga Hilda Orasan, Adela-Viviana Sitar-Taut
Format: Article
Language:English
Published: BMC 2020-02-01
Series:Artery Research
Online Access:https://doi.org/10.2991/artres.k-191224.169
_version_ 1797275319742234624
author Angela Cozma
Adriana Fodor
Vasile Negrean
Dorel Sampelean
Ionut Minciuna
Monica Oltean
Ionela Popovici
Sorina Coste
Alexandra Dadarlat
Dana Pop
Olga Hilda Orasan
Adela-Viviana Sitar-Taut
author_facet Angela Cozma
Adriana Fodor
Vasile Negrean
Dorel Sampelean
Ionut Minciuna
Monica Oltean
Ionela Popovici
Sorina Coste
Alexandra Dadarlat
Dana Pop
Olga Hilda Orasan
Adela-Viviana Sitar-Taut
author_sort Angela Cozma
collection DOAJ
description Abstract Background Chemerin represents a recently discovered chemokine influencing adipocyte function, lipolysis, apparently positively associated with insulin resistance. Purpose To evaluate the relationship between chemerin-insulin resistance scores in obese/diabetic patients. Methods 88 patients (66 women), mean age 61.96 ± 10.15. Cardiovascular risk factors (body weight, waist circumference, lipid fractions, smoking, diabetes, hypertension) and chemerin were assessed. Insulin resistance scores were calculated: Homeostatic model assessment (HOMA) = insulin (μU/mL)* glicemia (mg/dl)/405 and Quantitative insulin sensitivity check index (QUICKI = 1/[lg10 (insulin (μU/mL)) + lg10 (glicemia)]. Patients were categorized in obese only (20.5%), diabetics only (12.5%), obese and diabetics (14.8%) and non-diabetics-non obese (52.3%). Results 35.3% patients were obese, 27.3% diabetics, 79.5% hypertensive, 17% current smokers, 67% dyslipidaemic. The values of chemerin registered in the four groups were as follows: in diabetic + obese patients 7.98 ± 7.22 pg/ml (median 5.2), diabetics only 7.27 ± 5.24 pg/ml (5.6), obese only 8.42 ± 7.56 pg/ml (median 5.8), non-obese-non-diabetics 9.15 ± 7.64 pg/ml (median 7.15). Globally chemerin did not correlate with waist circumference, HDL-cholesterol, LDL-cholesterol, glicemia, insulin, HOMA index or QUICKI index. Going further with analysis, no significant correlations were found between chemerin and HOMA index and QUICKI index in diabetic + obese patients, obese only patients, diabetics only. But, in non-obese-non-diabetics significant correlations were found — between chemerin and glicemia (r = 0.3), HOMA index (r = 0.3, p = 0.03), QUICKI index (r = -0.310, p = 0.037), but not with waist circumference (r = 0.224, p = NS), HDL (r = 0.08, p = NS) or LDL (r = -0.06, p = NS). Conclusion Although many things need to be elucidated regarding the chemerin mechanism, it seems very probable to be involved in early insulin resistance.
first_indexed 2024-03-07T15:12:38Z
format Article
id doaj.art-f7166f51836f4e64909921e0a0d88817
institution Directory Open Access Journal
issn 1872-9312
1876-4401
language English
last_indexed 2024-03-07T15:12:38Z
publishDate 2020-02-01
publisher BMC
record_format Article
series Artery Research
spelling doaj.art-f7166f51836f4e64909921e0a0d888172024-03-05T18:15:09ZengBMCArtery Research1872-93121876-44012020-02-0125S1S186S18610.2991/artres.k-191224.169P149 The Relationship Between Insulin Resistance Scores Parameters and Chemerin in Diabetic and Obese PatientsAngela Cozma0Adriana Fodor1Vasile Negrean2Dorel Sampelean3Ionut Minciuna4Monica Oltean5Ionela Popovici6Sorina Coste7Alexandra Dadarlat8Dana Pop9Olga Hilda Orasan10Adela-Viviana Sitar-Taut11University of Medicine and Pharmacy “Iuliu Hatieganu”University of Medicine and Pharmacy “Iuliu Hatieganu”University of Medicine and Pharmacy “Iuliu Hatieganu”University of Medicine and Pharmacy “Iuliu Hatieganu”University of Medicine and Pharmacy “Iuliu Hatieganu”University of Medicine and Pharmacy “Iuliu Hatieganu”University of Medicine and Pharmacy “Iuliu Hatieganu”University of Medicine and Pharmacy “Iuliu Hatieganu”University of Medicine and Pharmacy “Iuliu Hatieganu”University of Medicine and Pharmacy “Iuliu Hatieganu”University of Medicine and Pharmacy “Iuliu Hatieganu”University of Medicine and Pharmacy “Iuliu Hatieganu”Abstract Background Chemerin represents a recently discovered chemokine influencing adipocyte function, lipolysis, apparently positively associated with insulin resistance. Purpose To evaluate the relationship between chemerin-insulin resistance scores in obese/diabetic patients. Methods 88 patients (66 women), mean age 61.96 ± 10.15. Cardiovascular risk factors (body weight, waist circumference, lipid fractions, smoking, diabetes, hypertension) and chemerin were assessed. Insulin resistance scores were calculated: Homeostatic model assessment (HOMA) = insulin (μU/mL)* glicemia (mg/dl)/405 and Quantitative insulin sensitivity check index (QUICKI = 1/[lg10 (insulin (μU/mL)) + lg10 (glicemia)]. Patients were categorized in obese only (20.5%), diabetics only (12.5%), obese and diabetics (14.8%) and non-diabetics-non obese (52.3%). Results 35.3% patients were obese, 27.3% diabetics, 79.5% hypertensive, 17% current smokers, 67% dyslipidaemic. The values of chemerin registered in the four groups were as follows: in diabetic + obese patients 7.98 ± 7.22 pg/ml (median 5.2), diabetics only 7.27 ± 5.24 pg/ml (5.6), obese only 8.42 ± 7.56 pg/ml (median 5.8), non-obese-non-diabetics 9.15 ± 7.64 pg/ml (median 7.15). Globally chemerin did not correlate with waist circumference, HDL-cholesterol, LDL-cholesterol, glicemia, insulin, HOMA index or QUICKI index. Going further with analysis, no significant correlations were found between chemerin and HOMA index and QUICKI index in diabetic + obese patients, obese only patients, diabetics only. But, in non-obese-non-diabetics significant correlations were found — between chemerin and glicemia (r = 0.3), HOMA index (r = 0.3, p = 0.03), QUICKI index (r = -0.310, p = 0.037), but not with waist circumference (r = 0.224, p = NS), HDL (r = 0.08, p = NS) or LDL (r = -0.06, p = NS). Conclusion Although many things need to be elucidated regarding the chemerin mechanism, it seems very probable to be involved in early insulin resistance.https://doi.org/10.2991/artres.k-191224.169
spellingShingle Angela Cozma
Adriana Fodor
Vasile Negrean
Dorel Sampelean
Ionut Minciuna
Monica Oltean
Ionela Popovici
Sorina Coste
Alexandra Dadarlat
Dana Pop
Olga Hilda Orasan
Adela-Viviana Sitar-Taut
P149 The Relationship Between Insulin Resistance Scores Parameters and Chemerin in Diabetic and Obese Patients
Artery Research
title P149 The Relationship Between Insulin Resistance Scores Parameters and Chemerin in Diabetic and Obese Patients
title_full P149 The Relationship Between Insulin Resistance Scores Parameters and Chemerin in Diabetic and Obese Patients
title_fullStr P149 The Relationship Between Insulin Resistance Scores Parameters and Chemerin in Diabetic and Obese Patients
title_full_unstemmed P149 The Relationship Between Insulin Resistance Scores Parameters and Chemerin in Diabetic and Obese Patients
title_short P149 The Relationship Between Insulin Resistance Scores Parameters and Chemerin in Diabetic and Obese Patients
title_sort p149 the relationship between insulin resistance scores parameters and chemerin in diabetic and obese patients
url https://doi.org/10.2991/artres.k-191224.169
work_keys_str_mv AT angelacozma p149therelationshipbetweeninsulinresistancescoresparametersandchemerinindiabeticandobesepatients
AT adrianafodor p149therelationshipbetweeninsulinresistancescoresparametersandchemerinindiabeticandobesepatients
AT vasilenegrean p149therelationshipbetweeninsulinresistancescoresparametersandchemerinindiabeticandobesepatients
AT dorelsampelean p149therelationshipbetweeninsulinresistancescoresparametersandchemerinindiabeticandobesepatients
AT ionutminciuna p149therelationshipbetweeninsulinresistancescoresparametersandchemerinindiabeticandobesepatients
AT monicaoltean p149therelationshipbetweeninsulinresistancescoresparametersandchemerinindiabeticandobesepatients
AT ionelapopovici p149therelationshipbetweeninsulinresistancescoresparametersandchemerinindiabeticandobesepatients
AT sorinacoste p149therelationshipbetweeninsulinresistancescoresparametersandchemerinindiabeticandobesepatients
AT alexandradadarlat p149therelationshipbetweeninsulinresistancescoresparametersandchemerinindiabeticandobesepatients
AT danapop p149therelationshipbetweeninsulinresistancescoresparametersandchemerinindiabeticandobesepatients
AT olgahildaorasan p149therelationshipbetweeninsulinresistancescoresparametersandchemerinindiabeticandobesepatients
AT adelavivianasitartaut p149therelationshipbetweeninsulinresistancescoresparametersandchemerinindiabeticandobesepatients